A. Nattermann & Cie Gmbh

A. Natternabb & Cie Gmbh

Harald O Borbe

Gerrit Prop

Gerd Hilboll

Jurgen Biedermann

Michael J Parnham

Erich Graf

Ille-Stephanie Doppelfeld

Sigurd Leyck

Hans-Heiner Lautenschlager

Josef P Lohr

Ferdinand Wirtz-Peitz

Helmut Wetzig

Joachim Uhlendorf

The invention relates to a new process for the treatment of hypertension and thromboembolic diseases in humans by simultaneous administration of (.+-.)- or (-)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene hydrochloride on the one side, and 4,5-dihydro-6-[4-(1-imidazolyl)-phenyl]-5-methyl-3(2H)-pyridazinone or 4,5-dihydro-6-[4-(1-imidazolyl)-thien-2-yl]-5-methyl-3(2H)-pyridazinone, on the other side, as the active substances.

Process for reducing reflex tachycardia in the treatment of hypertension

The invention relates to new imidazolylalkylthienyltetrahydropyridazines of the general formula I ##STR1## their acid addition salts as well as processes for their use in the treatment of cardiovascular and/or thromboembolic illnesses in humans.

Imidazolylalkylthienyl tetrahydropyridazines and processes for their use

The invention relates to new 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines of the Formula I ##STR1## and acid addition salts thereof and a process for the treatment of inflammatory and allergic processes in humans.

3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a

The invention concerns new substituted aminoalkanol phospholipids of the general Formula I ##STR1## and methods for the treatment of humans suffering from high blood-pressure (hypertension), from inflammatory illnesses, from tumors and/or atherosclerosis by administering medicaments containing such a compound as well as methods for plant protections.

Substituted aminoalkanol phospholipids

Growing community of inventors

Cologne, Germany

Harald O Borbe